No Bail for Pharma Firm Owner Accused of Producing Spurious Drugs Farhat Nasim24 Dec 2024 6:03 PM ISTThe court noted that granting bail would encourage other drug manufacturers to produce and market spurious drugs for easy money.
Only 5.9% Spurious Drug Cases Resolved: Parliamentary Panel Slams Govt Farhat Nasim23 Dec 2024 5:17 PM ISTNew Delhi: Take stringent action in a time bound manner for exemplary punishments for spurious/adulterated drugs, the Parliamentary Standing...
Indian Pharma Market to Hit Rs 2.38 Lakh Crore by 2025: Pharmarack Report Farhat Nasim22 Dec 2024 12:00 PM ISTNew Delhi: The Indian Pharma Market (IPM) is set to grow by 8.2% in 2025, reaching Rs 2.38 lakh crore under a realistic scenario, according to...
NPPA Fixes Retail Price of 65 New Drugs, Ceiling Price of 20 Formulations, Details Farhat Nasim21 Dec 2024 3:02 PM ISTNew Delhi: Through recent notifications, the National Pharmaceutical Pricing Authority (NPPA), under the Ministry of Chemicals and Fertilizers,...
NPPA Turns to Patent Office for Clarity on Drug Price Exemptions, Defers Intas, Biological E's Applications Farhat Nasim20 Dec 2024 6:11 PM ISTNew Delhi: The National Pharmaceutical Pricing Authority (NPPA) has sought expertise from the Indian Patent Office to assist in making decisions...
60% of Drug Inspector Posts Vacant at CDSCO, Parliamentary Panel Calls for Immediate Staffing Review Farhat Nasim19 Dec 2024 5:06 PM ISTNew Delhi: The Parliamentary Standing Committee on Chemicals and Fertilizers has raised concerns about the staffing situation at the Central Drugs...
Boxed Warning: USFDA issues most serious warning on menopause medicine Written By Ruchika Sharma18 Dec 2024 11:30 AM ISTUS Food and Drug Administration (USFDA) has added a boxed Warning highlighting the known risk of rare but serious liver injury associated with use of...
Eli Lilly and Company gets CDSCO panel nod to import, market Tirzepatide Multiple Dose Pen Written By Susmita Roy17 Dec 2024 6:00 PM ISTNew Delhi: The pharmaceutical major Eli Lilly and Company (India) has got the go-ahead from the Subject Expert Committee (SEC) functional under the...
Indian Pharma Market Grows at 9.9%, Vaccine Sales See Sharp Decline: Pharmatrac Report Farhat Nasim16 Dec 2024 5:27 PM ISTNew Delhi: The Indian Pharmaceutical Market (IPM) posted a solid 9.9% increase in value, reaching Rs 19,388 crore in November 2024. This growth was...
Zydus Lifscience Gets CDSCO Panel Nod To study Anti-cancer Drug Pertuzumab Written By Dr. Divya Colin15 Dec 2024 6:00 PM ISTNew Delhi: Zydus Lifsciences has got approval from the Subject Expert Committee SEC functional under the Central Drug Standard Control Organisation...
Indian Pharma Market Posts Robust 10.7% Growth in November, Foracort Tops Sales: IQVIA Farhat Nasim14 Dec 2024 5:52 PM ISTLeading the market, Foracort, a respiratory drug widely used for asthma, secured the top position among brands with sales of Rs 82 crore.
Glenmark Pharmaceuticals Gets CDSCO Panel Nod To Import and Market anticancer Drug Zanubrutinib Capsules 80mg Written By Dr. Divya Colin13 Dec 2024 6:00 PM ISTNew Delhi: Pharmaceutical major Glenmark Pharmaceuticals has got the go-ahead from the Subject Expert Committee (SEC) functional under the Central...
